Gain Therapeutics, Inc.
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Legal Proceedings
As previously disclosed, the Company and two members of its board of directors were named as defendants in a lawsuit filed in the Circuit Court of Maryland for Montgomery County by Matthias Alder, the Company’s former Chief Executive Officer. Following mediation, on May 13, 2025 the parties reached an agreement in principle to settle the case and subsequently executed a settlement agreement which, if not revoked during a 7-day revocation period, will become effective on May 20, 2025 and require dismissal of the lawsuit.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.